Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.
Press releases published on June 17, 2025

MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced the results of matters voted on at …

Life Extension Expands Healthy Aging Supplements Line
Fort Lauderdale, FL, June 17, 2025 (GLOBE NEWSWIRE) -- “Aging gracefully” can mean a lot of things: following an exercise regimen in your golden years, eating nutrient-dense foods, or even trying a new hobby to keep your mind limber. For many, dietary …

USAHS & The Brain Center Unite to Support Dementia Caregivers with Hands-On Course
MIAMI, June 17, 2025 (GLOBE NEWSWIRE) -- In recognition of Alzheimer’s …

FDA Grants Orphan Drug Designation to Medicovestor’s First-in-Class ADC for Pancreatic Cancer
NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Medicovestor, Inc., a biotechnology company advancing next-generation antibody-drug conjugates (ADCs), announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to …

Prime Biome Gummy: Examining the Science and Safety of a Legal Gut-Skin Health Formula
LARGO, Fl, June 17, 2025 (GLOBE NEWSWIRE) -- Amid rising interest in gut health and its connection to overall wellness, a new supplement called Prime Biome Gummy has entered the market, offering a science-based approach to support both digestive and skin …

BioRestorative Announces Share Repurchase Program
MELVILLE, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced …

Project Sunshine Announces "Longest Day of Play" Fundraising Campaign Planned for June 20th Alongside Refreshed Visual Identity
NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Project Sunshine, an organization supporting children and families with medical needs through the power of play, is launching a major fundraising campaign on Friday, June 20th, coinciding with the summer solstice …

Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases
Northstrive Biosciences and Yuva Biosciences previously announced a collaboration leveraging MitoNova™, YuvaBio’s proprietary mitochondrial science-focused artificial intelligence platform, to discover and develop novel pharmaceutical treatments for …

Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth
--New CCO to Lead U.S. Commercialization of Fertility Products, Including FemaSeed®, and Expand Strategic Global Partnerships Across Full Portfolio-- ATLANTA, June 17, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc. (Nasdaq: FEMY), a leading biomedical innovator …

BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank
Company to generate and analyze molecular profiles from over 17,000 samples from the HUNT Biobank in Norway to accelerate discovery of drug targets for aging-related diseases New data deepen platform insights into the biology of resilience across multiple …

LogicMark, Inc. Appoints Jeffrey Durkin as Senior Vice President of Sales to Drive Strategic Growth in the Care Economy and Personal Safety Markets
LOUISVILLE, Ky, June 17, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (the "Company"), a provider of personal emergency response systems (PERS), health communication devices, and technology for the growing safety and care economy, announced the appointment of …

Lark Health Names Industry Veteran Matthew Gibbs as President and Launches LarkVantage, an A.I. GLP-1 Cost Containment Platform
MOUNTAIN VIEW, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Lark Health, a cardiometabolic and weight management platform that has supported nearly 2.5 million patients with 24/7 counseling, remote patient monitoring, and clinical escalations, today announced …

Omada Health’s Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks
SAN FRANCISCO, June 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, released new data1 demonstrating that Omada’s GLP-1 companion program significantly improved persistence rates for GLP-1 …

Capricor Therapeutics Announces Orphan Drug Designation for Becker Muscular Dystrophy and Regulatory Progress for Duchenne Muscular Dystrophy Program
U.S. FDA grants Orphan Drug Designation to Deramiocel for the treatment of Becker Muscular Dystrophy, broadening Capricor’s focus in neuromuscular diseases Capricor remains on track for the August 31, 2025, PDUFA date for Deramiocel in Duchenne Muscular …

Alira Health Launches Patient Engagement Certification for Life Sciences Organizations
FRAMINGHAM, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- Alira Health is a global healthcare consultancy that helps life sciences companies deliver patient-centered solutions through integrated clinical, strategic, and digital expertise. Today, the company …

Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate
$452.5 million in total milestone payments $2.5 million in near-term payments Double-digit royalties on future net product sales 3.5% equity stake in Intact Therapeutics HANOVER, Md., June 17, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq …

Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award Winner
POMPANO BEACH, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- Ernst …

AIM ImmunoTech Resumes Trading on NYSE American
OCALA, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that its common stock has resumed trading on the NYSE American under the symbol "AIM" and CUSIP 00901B303, effective at the …

Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis
VANCOUVER, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to report that the United States Patent and Trademark Office (USPTO) has issued a …

Lipella Pharmaceuticals Announces U.S. Patent Issuance for Diagnostic Technology
PITTSBURGH, June 17, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet need, today announced the …